未登录

X

Xinyu Liu

chinese academy of medical sciences - peking union medical college

H指数:2

被引数:161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial

BRITISH JOURNAL OF OPHTHALMOLOGY

IF3.5

2025-03-010

PRE

Gut microbiome metabolites, molecular mimicry, and species- level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors

IF10.8

2024-11-011

PRE

Efficacy and safety results from the phase II study of Timdarpacept in combination with tislelizumab, in prior anti-PD-1 failed classical Hodgkin lymphoma

Timdarpacept联合tislelizumab治疗既往抗PD-1治疗失败的经典霍奇金淋巴瘤的II期研究有效性与安全性结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China

GASTROENTEROLOGY REPORT

IF4.2

2024-06-070

OAAI

Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma

ANNALS OF ONCOLOGY

IF65.4

2013-10-01126

OA

Outcomes of ALK-negative Anaplastic Large Cell Lymphoma are Superior to Peripheral T-cell Lymphoma, Not Otherwise Specified: Report From a Single Chinese Institution

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2012-11-010

OAAI